57790-51-9Relevant academic research and scientific papers
PROSTAGLANDIN ANALOGS AND USES THEREOF
-
Paragraph 0144-0146, (2021/05/14)
The present invention relates to pharmaceutical composition for the prevention or treatment of a disease, disorder, or condition associated with Nurr1, including, as an active ingredient, a prostaglandin analog or a pharmaceutically acceptable salt thereof, wherein the compound has excellent effects in inducing Nurr1, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of a disease, disorder, or condition associated with Nurr1, in particular, cancer, autoimmune disease such as rheumatoid arthritis, schizophrenia, manic depression and neurodegenerative disease such as Alzheimers disease or Parkinson's disease.
Substituted tolyl esters of PGE1
-
, (2008/06/13)
Substituted phenyl and naphthyl esters of PGE1, 15-alkyl-PGE1, and 15(R)-15-alkyl-PGE1, and their racemic forms, and processes for producing them are disclosed. The products are useful for the same pharmacological and medi
